SCHEMBL23303591

SCHEMBL23303591

O=C(CCc1cc2ccc(F)cc2cn1)N1CC=C(c2cccc(F)c2)CC1

nearest known ligand 0.49

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
▸ PARP1 P09874 4/20 0.49
▸ PARP2 Q9UGN5 1/20 0.49
▸ MEN1 O00255 1/20 0.46
▸ KMT2A Q03164 1/20 0.46
▸ NAMPT P43490 1/20 0.41
▸ MAPT P10636 3/20 0.41
▸ LMNA P02545 1/20 0.41
▸ HTT P42858 1/20 0.41
▸ NPSR1 Q6W5P4 1/20 0.41
▸ KDM4E B2RXH2 1/20 0.39
▸ MAPK1 P28482 1/20 0.38
▸ DGAT1 O75907 1/20 0.38
▸ CDK9 P50750 3/20 0.38
▸ CCNT1 O60563 1/20 0.38
▸ KHK P50053 1/20 0.38
▸ NPC1 O15118 1/20 0.38
▸ ALDH1A1 P00352 1/20 0.38
▸ HPGD P15428 1/20 0.38
▸ ALOX15 P16050 1/20 0.38
▸ CASP3 P42574 1/20 0.38

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL23303869 0.92 PARP1 (0.55) PARP1PARP2MEN1KMT2ANAMPT
SCHEMBL23303162 0.88 PARP1 (0.47) PARP1PARP2MEN1KMT2ANAMPT
SCHEMBL23303966 0.79 PARP1 (0.56) PARP1PARP2MEN1KMT2ANAMPT
SCHEMBL29882230 0.78 PARP1 (0.56) PARP1PARP2MEN1KMT2AMAPT
SCHEMBL23303585 0.78 PARP1 (0.56) PARP1PARP2MEN1KMT2AMAPT
SCHEMBL23302528 0.74 CCNT1 (0.46) PARP1PARP2MEN1KMT2ANAMPT
SCHEMBL23303546 0.72 PARP1 (0.50) PARP1PARP2MEN1KMT2ANAMPT
SCHEMBL29882275 0.72 PARP1 (0.50) PARP1PARP2MEN1KMT2ANAMPT
SCHEMBL23302575 0.72 PARP1 (0.50) PARP1PARP2MEN1KMT2ANAMPT
SCHEMBL29882057 0.72 PARP1 (0.50) PARP1PARP2MEN1KMT2ANAMPT

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 1 patent. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
WO-2021086077-A1 ISOQUINOLINONE DERIVATIVE, PREPARATION METHOD THEREFOR, AND PHARMACEUTICAL COMPOSITION, COMPRISING SAME AS ACTIVE INGREDIENT, FOR PREVENTION OR TREATMENT OF POLY(ADP-RIBOSE)POLYMERASE-1 (PARP-1)-ASSOCIATED DISEASE 충남대학교 산학협력단 2021-05-06 — — WO disclosed
Send feedback